EP2329848
Lixisenatíð sem viðbótameðferð við insúlín glargín og metformín til að meðhöndla sykursýki af gerð 2
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
13.11.2009EP published:
24.10.2012EP application number:
09175877.1
EP translation filed:
19.12.2012Grant published:
15.1.2013EPO information:
European Patent Register
Max expiry date:
12.11.2029Expiry date:
12.11.2019
Title:
Lixisenatide as add-on therapy to insulin glargine and metformin for treating type 2 diabetes
Timeline
Today
13.11.2009EP application
24.10.2012EP Publication
19.12.2012Translation submitted
15.1.2013Registration published
12.11.2019Expires
Owner
Name:
Sanofi-Aventis Deutschland GmbHAddress:
Brüningstraße 50, 65929, Frankfurt am Main, DE
Inventor
Name:
Silvestre, LouiseAddress:
Paris, FR
Name:
Souhami, ElisabethAddress:
Paris, FR
Name:
Wei, XiaodanAddress:
Bridgewater, NJ, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Classification
Categories:
A61K 31/155, A61K 38/26, A61K 38/28, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 27.11.2012
Expires: 12.11.2013
Payer: Sigurjónsson & Thor ehf.
Number: 5
Paid: 9.10.2013
Expires: 12.11.2014
Payer: Árnason Faktor
Number: 6
Paid: 7.10.2014
Expires: 12.11.2015
Payer: Árnason Faktor
Number: 7
Paid: 12.10.2015
Expires: 12.11.2016
Payer: Árnason Faktor
Number: 8
Paid: 13.10.2016
Expires: 12.11.2017
Payer: Árnason Faktor
Number: 9
Paid: 5.10.2017
Expires: 12.11.2018
Payer: Árnason Faktor
Number: 10
Paid: 5.10.2018
Expires: 12.11.2019
Payer: Árnason Faktor